Macrogol/Polyethylene Glycol (PEG) Market Size – USD 3212.1 million in 2018, Market Growth - CAGR of 5.3%, PEG Industry Trends – Increasing use in Cancer therapy.

New York, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Increasing growth of food industry and pharmaceutical in emerging economics fuel the growth of the macrogol/polyethylene glycol market.

According to the current analysis of Reports and Data, the global macrogol/polyethylene glycol (PEG) market was valued at USD 3,212.1 million in 2018 and is expected to reach USD 4,934.6 million by year 2026, at a CAGR of 5.3%. Macrogol have been shown to provide water solubility and biocompatibility in medicines and different applications, and the ability to attach a range of reactive functional groups to the terminal positions of these polymers has greatly increased their utility. For instance, Macrogol 400 is very hydrophilic, which renders it a useful ingredient in drug formulations to augment the solubility and bioavailability of weakly water-soluble drugs.

The pharmaceutical industry is the emerging segment in this industry due to the fact of growing the manufacturing of eye drops and laxatives coupled with the increase of the pharmaceutical industry has improved the use of macrogol as a solvent which will force to increase the market growth in future. Besides, rising demand for water-based coatings and paints for utility in automobile and development industries has additionally elevated the demand for macrogol/polyethylene glycol. This will additionally have an on affect the market positively.

However, the presence of alternatives, for mono ethylene glycol (MEG) and a range of different glycol ethers, will pose a credible risk to the polyethylene glycol industry and negatively affect its future. The stringent environmental protocols associated to the manufacturing of private care and medical products may additionally obstruct the market boom for polyethylene glycol.     

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/1707

Further key findings from the report suggest

• The PEG-3350 segment is projected to increase at a CAGR of 5.8% during the forecast period. This grade is used for short-term relief of constipation as well as for long-term use in constipation of various causes, including in multiple sclerosis and Parkinson's disease patients (an oftenoverlooked non-motor symptom) as well as constipation caused by pharmaceutical drugs such as opioids and anticholinergics.
• Chronic constipation is a common disorder, affecting between 2-35% of the population, according to a recent report from European Review for Medical and Pharmacological Sciences. It is characterized by dry feces and infrequent excretions from the body. Macrogol improves stool frequency and consistency, thus making it a suitable drug to treat chronic constipation.
• Key participants include – BASF, Sigma Aldrich, DOW Chemical Company, Lotte Chemical, Ineos, Croda, Liaoning Oxiranchem, Jiangsu Haian Petrochemical Plant, Shanghai Bronkow Chemical, and Oxiteno. BASF is a key player in the poloxamer market. With a global presence in North America, Europe, Asia Pacific, and South America, Africa & Middle East, the company offers macrogols by the name – ‘Kollisolv’. As of 2018, the company’s total revenue accounted for USD 73.9 billion.

To identify the key trends in the industry, click on the link below:   https://www.reportsanddata.com/report-detail/macrogol-polyethylene-glycol-peg-market

Segments covered in the report:

For the purpose of this report, Reports and Data has segmented the global macrogol/polyethylene glycol market on the basis of type, technology type, end use, and region:                     

Type (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• PEG 200
• PEG 400
• PEG 3350
• PEG 4000
• PEG 6000
• PEG 8000
• Others

Administration Route (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Oral
• Nasogastric
• Ophthalmic
• Topical

Usage (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Excipient
• API

End Use (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• Pharmaceutical Uses
• Veterinary Health
• Biotechnology
• Biomedical
• Other end uses

Order Now: https://www.reportsanddata.com/checkout-form/1707

Regional Outlook (Volume, Metric Tons; 2019-2026 and Revenue, USD Million; 2019-2026)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of the Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia-Pacific
• Middle East & Africa
  • Latin America
• Brazil

Browse more similar reports on Polymers and Resins category by Reports And Data

Polymer Emulsion Market - https://www.reportsanddata.com/report-detail/polymer-emulsion-market

Automotive Plastic Market - https://www.reportsanddata.com/report-detail/automotive-plastic-market

Polycarbonate Films Market - https://www.reportsanddata.com/report-detail/polycarbonate-films-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-800-819-3052
E-mail: sales@reportsanddata.com